These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 37849974)

  • 1. Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches.
    O'Reilly C; Mills S; Rea MC; Lavelle A; Ghosh S; Hill C; Ross RP
    Microbiome Res Rep; 2023 Sep; 2(4):35. PubMed ID: 37849974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
    Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
    Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
    [No Abstract]   [Full Text] [Related]  

  • 4. Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
    Healey GR; Celiberto LS; Lee SM; Jacobson K
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet and Microbiome-Directed Therapy 2.0 for IBD.
    Ananthakrishnan AN; Whelan K; Allegretti JR; Sokol H
    Clin Gastroenterol Hepatol; 2024 Jul; ():. PubMed ID: 38992408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease.
    Radhakrishnan ST; Alexander JL; Mullish BH; Gallagher KI; Powell N; Hicks LC; Hart AL; Li JV; Marchesi JR; Williams HRT
    Aliment Pharmacol Ther; 2022 Jan; 55(1):26-48. PubMed ID: 34751954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease.
    Zuo T; Ng SC
    Front Microbiol; 2018; 9():2247. PubMed ID: 30319571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases.
    Bernstein CN; Forbes JD
    Inflamm Intest Dis; 2017 Nov; 2(2):116-123. PubMed ID: 30018962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
    Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
    Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
    McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
    Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update.
    Selvamani S; Mehta V; Ali El Enshasy H; Thevarajoo S; El Adawi H; Zeini I; Pham K; Varzakas T; Abomoelak B
    Saudi J Biol Sci; 2022 May; 29(5):3546-3567. PubMed ID: 35844369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
    Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
    PeerJ; 2022; 10():e13205. PubMed ID: 35497193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and microbiome in the beginning of the sequence of gut inflammation.
    Ceballos D; Hernández-Camba A; Ramos L
    World J Clin Cases; 2021 Dec; 9(36):11122-11147. PubMed ID: 35071544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease.
    Hart L; Verburgt CM; Wine E; Zachos M; Poppen A; Chavannes M; Van Limbergen J; Pai N
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.
    Elzayat H; Mesto G; Al-Marzooq F
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis.
    Zheng J; Sun Q; Zhang J; Ng SC
    United European Gastroenterol J; 2022 Dec; 10(10):1091-1102. PubMed ID: 36461896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome-phage interactions in inflammatory bowel disease.
    Federici S; Kviatcovsky D; Valdés-Mas R; Elinav E
    Clin Microbiol Infect; 2023 Jun; 29(6):682-688. PubMed ID: 36191844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.